Treatment with thi, an inhibitor of sphingosine-1-phosphate lyase (sgpl1), modulates glycosphingolipid metabolism and results therapeutically effective in a mouse model of huntington's disease
I: Experimental therapeutics – preclinical(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined